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A current major challenge in leprosy control is the prevention of permanent disabilities. 
Host pathological inflammatory responses termed type 1 reaction (T1R) are a leading 
cause of nerve damage for leprosy patients. The environmental or inherited factors that 
predispose leprosy cases to undergo T1R are not known. However, studies have shown 
an important contribution of host genetics for susceptibility to T1R. We have previously 
identified variants encompassing the TNFSF15/TNFSF8 genes as T1R risk factors in 
a Vietnamese sample and replicated this association in a Brazilian sample. However, 
we failed to validate in Brazilian patients the strong association of TNFSF15/TNFSF8 
markers rs6478108 and rs7863183 with T1R that we had observed in Vietnamese 
patients. Here, we investigated if the lack of validation of these variants was due to 
age-dependent effects on association using four independent population samples, two 
from Brazil and two from Vietnam. In the combined analysis across the four samples, 
we observed a strong association of the TNFSF15/TNFSF8 variants rs6478108, 
rs7863183, and rs3181348 with T1R (pcombined =  1.5E−05, pcombined =  1.8E−05, and 
pcombined =  6.5E−06, respectively). However, the association of rs6478108 with T1R 
was more pronounced in leprosy cases under 30  years of age compared to the 
global sample [odds ratio (OR) =  1.95, 95% confidence interval (CI) =  1.54–2.46, 
pcombined = 2.5E−08 versus OR = 1.46, 95% CI = 1.23–1.73, pcombined = 1.5E−05]. A 
multivariable analysis indicated that the association of rs6478108 with T1R was inde-
pendent of either rs7863183 or rs3181348. These three variants are known regulators 
of the TNFSF8 gene transcription level in multiple tissues. The age dependency of 
association of rs6478108 and T1R suggests that the genetic control of gene expres-
sion varies across the human life span.
Keywords: age at disease diagnosis, leprosy, excessive inflammatory response, TNFSF8, TNFSF15, type 1 
reaction, association studies, crohn’s disease
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inTrODUcTiOn
Leprosy is a chronic dermato-neurological infectious disease 
caused by Mycobacterium leprae. Due to leprosy control meas-
ures, the prevalence of the disease has been reduced to less than 
1/10,000 of the global population. However, leprosy persists as 
major public health problem in sub-national foci. The incidence of 
new cases has shown only a gradual decline over the last 10 years 
and as of 2015 stood at 210,758 (1). A major goal of the global 
leprosy strategy is the reduction of disabilities due to leprosy. In 
leprosy, a major cause of tissue damage and permanent disability 
are host pathological inflammatory episodes termed type 1 reac-
tions (T1Rs). Hence, translational research activities are dedicated 
toward a better understanding of T1Rs and their relationship with 
overall leprosy pathogenesis. The main dermato-pathological 
findings in T1R are an increased infiltrate of lymphocytes in the 
dermis, intragranuloma edema, and loss of the normal granuloma 
structure (2, 3). T1Rs are common and affect up to 50% of leprosy 
patients depending on the endemic settings with many patients 
presenting recurring episodes (4). The trigger for a T1R episode 
is not known, but studies have provided evidence of a genetic 
component in T1R susceptibility (4–8).
We have recently identified single-nucleotide variants (SNVs) 
in the vicinity of the neighboring genes TNFSF15 and TNFSF8 
as risk factors of T1R (8). A set of SNVs associated with T1R in 
two Vietnamese and Brazilian samples correlated with TNFSF8 
gene expression levels (8). The T1R risk locus in Brazilians was 
restricted to SNVs physically encompassing the TNFSF8 gene. 
However, the strongest association with T1R in the Vietnamese 
population was observed for two SNVs (rs6478108 and rs7863183) 
located distal to the TNFSF8 gene. Although divergences in the 
linkage disequilibrium pattern across populations may account 
for the differences of T1R association with SNVs in the TNFSF8 
gene region, age at onset of disease was not taken into account. It 
was shown by twin studies that the heritability of major immune 
traits is strongly age dependent (9). Likewise, we have previously 
shown for the LTA and PARK2 genes that the age at leprosy diag-
nosis is crucial for the association of certain SNVs and leprosy 
per se (10, 11). The age at leprosy diagnosis for T1R cases in the 
Brazilian sample was two times higher than the age at leprosy 
diagnosis in the Vietnamese sample. Therefore, the lack of valida-
tion for T1R and TNFSF8 distal SNVs in the Brazilian sample may 
reflect age-dependent mechanisms of gene expression. To address 
the age dependency of genetic risk factors in T1R, we revisited 
the association of the TNFSF15/TNFSF8 locus with T1R by 
focusing on three key T1R risk SNVs (rs3181348, rs6478108, and 
rs7863183) in the Brazilian and Vietnamese samples and evalu-
ated the age-dependent strength of the evidence for association.
MaTerials anD MeThODs
ethics approval statement
Written informed consent was obtained from all subjects partici-
pating in the study. All minors assented to the study, and a parent 
or guardian provided the informed consent on their behalf. The 
study was approved by ethics committees of the participating 
centers and conducted according to the principles expressed in 
the Declaration of Helsinki.
Population sample
For the current study, we evaluated four independent popula-
tions. The Vietnam I and the Brazil I population samples have 
been described previously (8). Briefly, the Vietnam I sample 
consisted of 224 T1R-affected offspring from our family-based 
design approach (8). The Brazil I sample comprised 758 leprosy 
cases enrolled from the Central-West Region of Brazil with 374 
of these being T1R affected and the remaining 384 being T1R free 
(8). To study the effect of age at leprosy diagnosis on the strength 
of association of T1R with the TNFSF15/TNFSF8 locus, two new 
population samples were enrolled and named Vietnam II and 
Brazil II (Table 1) (12). The Vietnam II population sample com-
prised 816 leprosy-affected patients of which 253 presented T1R, 
while the remaining 563 were T1R free. The Brazil II population 
sample comprised 136 T1R-affected and 170 T1R-free leprosy 
patients recruited from Rio de Janeiro in the Southeast region of 
Brazil. As T1R affects predominantly leprosy patients classified 
as borderline within the Ridley and Jopling leprosy spectrum, 
T1R-free controls were also selected mainly from the borderline 
form of the disease. Details regarding the clinical characteristics 
of the Vietnam II and Brazil II samples can be found in Table S1 
in Supplementary Material.
genotyping
For the current study, three SNVs previously associated with T1R 
(rs6478108, rs7863183, and rs3181348) were genotyped using the 
SEQUENOM MassARRAY platform or obtained by a larger scale 
effort using the high-throughput Illumina platform (13). The five 
SNVs presented call rate >0.9 and were in Hardy–Weinberg equi-
librium with p values >0.05 in the control groups in all study phases.
statistical approach
To investigate if TNFSF15/TNFSF8 SNVs’ association with T1R 
was restricted to an early age at leprosy diagnosis, we performed 
a stratified analysis dividing the T1R-affected cases into three 
age categories: (i) children and young adults up to 29 years old, 
TaBle 1 | age at leprosy diagnosis of four studied samples.
T1r-affected T1r-free
age at leprosy diagnosis 
(years)
age at leprosy diagnosis 
(years)
Patients Median Mean (sD) Patients Median Mean (sD)
Discovery
Vietnam Ia 224 18 19.7 (7.2) n.a. n.a. n.a.
replication
Vietnam II 262 25 26.5 (10.1) 576 24 23.8 (7.8)
Validation
Brazil Ia 374 47 46.7 (15.8) 384 40 41.8 (16.9)
Brazil II 136 44 43.0 (17.8) 170 41 41.1 (17.6)
T1R, type 1 reaction; n.a., not applicable.
aClinical characteristics and univariable analysis for association with T1R were 
previously reported for these samples (8).
FigUre 1 | age at leprosy diagnosis density in leprosy type-1 reaction (T1r)-affected patients. The age distribution of 996 T1R-affected leprosy cases 
from the 4 studied populations is plotted according to the density of cases.
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(ii) adults from 30 to 60 years old, and (iii) seniors above 60 years 
old. The association analysis was carried out in each age strata at 
first, and finally, combined analysis with the overall sample was 
applied for comparison. For the Vietnam I sample, pseudo-sib 
controls were generated based on our family-based approach 
data (8). Briefly, the non-transmitted allele from parents to T1R-
affected offspring in a transmission disequilibrium test was used 
to create up to three unaffected pseudo-sibs per family, one for 
each possible genotype (14). The pseudo-sibs matched the clinical 
characteristics of the offspring of which it derived from; therefore, 
it can only be compared in a matched case–control design. This 
strategy was used to estimate SNVs’ risk in odds ratio (OR) format 
and their respective confidence intervals (CIs) using conditional 
logistic regression in SAS software (version 9.3; SAS Institute). For 
the replication and validation phases, both additive and dominant 
models of inheritance were tested using the same reference allele 
for each SNV in PLINK 1.07 and the best p-value was displayed 
(15). In each age at leprosy diagnosis category, T1R-affected cases 
were compared to the totality of T1R-free cases as controls. No 
adjustments were made in the logistic procedures as gender was 
not associated with T1R risk and clinical form of leprosy was a 
criterion for sample selection. The two-sided test is given for all 
samples as the research question focused on the effect of an allele 
independent of the direction, which for the Brazilian sample was 
different in the initial T1R versus TNFSF8/TNFSF15 study (8).
To perform a combined analysis in each age category and the 
overall sample, we performed a meta-analysis in the software 
METAL (16). The contribution of each sample to the final statistic 
was weighted according to the effect size (β) derived from the 
logistic procedure and its respective SEs. To estimate popula-
tion heterogeneity, the I2 statistic was calculated. The I2 values 
correspond to the percentage of variance in a meta-analysis 
that is attributed to study heterogeneity. Minor allele frequen-
cies, Hardy–Weinberg equilibrium, and linkage disequilibrium 
structure were calculated in Haploview 4.2 (17).
The multivariable analysis was carried out with stepwise 
conditional logistic regression in SAS software. The haplotype 
analysis was performed with the THESIAS software (18). Briefly, 
T1R-affected subjects were compared to T1R-free (Vietnam II, 
Brazil I, and Brazil II) or with the untransmitted haplotypes from 
parents to offspring (Vietnam I) in a matched case–control design.
resUlTs
A substantial variation of age at leprosy diagnosis for T1R-affected 
cases was observed between the Vietnamese and Brazilian sam-
ples (Figure 1). The largest difference in age at leprosy diagnosis 
was observed for the Vietnam I and the Brazil I samples (median 
of 18 and 47 years, respectively; p < 0.0001), while the difference 
between the two Brazilian samples (Brazil I and Brazil II) was 
small (median of 47 and 44 years, respectively; p = 0.03). In addi-
tion, for the Brazilian patients, the age at diagnosis was spread 
over a larger age range (Figure 1). By contrast, the Vietnamese 
samples presented a narrower age-at-diagnosis distribution 
with the majority of T1R-affected cases being diagnosed before 
30 years of age (Figure 1).
TaBle 2 | effect of age at leprosy diagnosis on association of rs6478108 
with T1r.
rs6478108-g allele
age at leprosy diagnosis samples Or (95% ci) p Value
<30 Vietnam I 2.34 (1.59–3.45) 1.50E−05
Vietnam II 1.37 (1.06–1.75) 0.02
Brazil I 2.08 (0.96–4.50) 0.06
Brazil II 4.97 (1.88–13.2) 0.001
Combined 1.95 (1.54–2.46) 2.50E−08
I2 (p value) 55.3 0.06
30–60 Vietnam I 0.40 (0.13–1.28) 0.12
Vietnam II 1.35 (0.94–1.94) 0.1
Brazil I 0.69 (0.36–1.33) 0.27
Brazil II 1.85 (0.73–4.66) 0.19
Combined 1.04 (0.81–1.34) 0.75
I2 (p value) 53.6 0.07
>60 Vietnam I n.a. n.a.
Vietnam II n.a. n.a.
Brazil I 0.76 (0.29–2.05) 0.59
Brazil II 1.85 (0.75–4.57) 0.18
Combined 1.21 (0.74–2.00) 0.44
I2 (p value) 0 0.43
All ages Vietnam I 2.13 (1.45–3.13) 2.10E−04
Vietnam II 1.36 (1.09–1.70) 0.007
Brazil I 0.93 (054–1.57) 0.77
Brazil II 2.48 (1.14–5.37) 0.02
Combined 1.46 (1.23–1.73) 1.50E−05
I2 (p value) 54.9 0.06
OR, odds ratio; CI, confidence interval; n.a., not applicable; T1R, type-1 reaction.
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The association of rs6478108 with T1r is 
age Dependent
The G-allele of the TNFSF15 intron variant rs6478108 had previ-
ously been associated with T1R in the Vietnam I population. 
However, we failed to validate rs6478108 as a T1R risk factor 
in the Brazil I sample, despite good power to detect an effect of 
similar size as found in Vietnam I. Indeed, given the observed 
minor allele frequency of 0.31 of Brazil I and assuming a type 
1 error of 0.05, power was 95.7% (additive model) and 81.5% 
(dominant model) to detect the lower boundary risk (OR = 1.45) 
observed for Vietnam I (Table  2; Figure  2). By contrast, the 
G-allele of rs6478108 was significantly associated with T1R risk 
in the Vietnam II (p = 0.007) and Brazil II samples (p = 0.02) even 
though these populations, compared to Brazil I, presented a lower 
number of T1R-affected subjects (Figure 2; Table 2).
The proportion of T1R-affected cases diagnosed with leprosy 
before 30 years for Vietnam I and Vietnam II was approximately 
93 and 70%, respectively, while in Brazil I and Brazil II, this 
age category represented only 16 and 27%, respectively, of 
T1R patients. We hypothesized that the small proportion of 
patients younger than 30 years at leprosy diagnosis in the Brazil 
I sample could be masking a true association of rs6478108 and 
T1R. When a stratified analysis by age at leprosy diagnosis, the 
under 30-year at-diagnosis category displayed the most signifi-
cant evidence for association of rs6478108 with T1R across all 
samples. Consequently, in the combined analysis of all samples, 
the under 30-year at-diagnosis subset presented a stronger OR 
and a more significant p-value than the overall combined sample 
(OR = 1.95, p = 2.5 × 10−8 and OR = 1.46, p = 1.5 × 10−5, respec-
tively). The most striking impact of age at leprosy diagnosis 
was observed for the Brazilian I sample (Table 2; Figure 2). In 
Brazil I, rs6478108 was not associated with T1R in the overall 
analysis with the G-allele tending toward protection for T1R 
(OR  =  0.93, p  =  0.77). However, in the under 30-year age 
group, the G-allele of rs6478108 showed a strong trend toward 
association with T1R (OR = 2.08, p = 0.06; Table 2; Figure 2). 
The effect of age was also strong in the Brazil II sample where 
the risk was twofold higher in the under 30-year at-diagnosis 
group compared to the overall sample (OR = 4.97, p = 0.001 and 
OR = 2.48, p = 0.02, respectively). Although Brazil I and Brazil 
II were analyzed separately, linkage disequilibrium analysis of 
the Brazil II revealed near identity with the Brazilian I sample 
(Figure S1 in Supplementary Material). A combined analysis of 
both Brazilian samples confirmed the age-dependent association 
of rs6478108 with T1R (Figure S2 in Supplementary Material). 
No significant association of rs6478108 with T1R was observed 
for the age groups of 30–60 years and over 60 years at leprosy 
diagnosis (Table 2; Figure 2).
In contrast to rs6478108, both rs7863183 and rs3181348 did 
not present a strong age-at-diagnosis effect of their association 
with T1R (Table S2 and Figures S3 and S4 in Supplementary 
Material). Indeed, rs7863183 and rs3181348 remained sig-
nificantly associated with T1R in the age-at-diagnosis category 
from 30 to 60 years (p = 0.04 for both), suggesting a difference 
in the underlying mechanism of T1R susceptibility mediated by 
rs6478108 and rs7863183 (Table S2 and Figures S3 and S4 in 
Supplementary Material). To follow-up on this observation, we 
conducted a multivariable analysis to investigate independence 
of association of the three SNVs with T1R.
Two independent associations with T1r in 
the TNFSF8/TNFSF15 locus
When the three SNVs were included in a multivariable model, 
rs6478108 and rs7863183 maintained the significant association 
with T1R, while rs3181348 lost significance (Table 3). The associa-
tion of rs6478108 and rs7863183 with T1R was also observed in 
the <30 years group at leprosy diagnosis reinforcing the observa-
tion that the signal captured by these two variants is independent 
(Table 3). The SNV selected first by the multivariable procedure 
flipped when only the <30 years group was evaluated. In the overall 
sample, rs7863183 was the most significant SNV, while rs6478108 
was selected first in the <30 years group. This observation is in 
agreement with the stronger effect of rs6478108 in early-onset 
cases of T1R. As the multivariable analysis suggested that the 
association of rs6478108 and rs7863183 with T1R was independ-
ent, we performed a haplotype analysis to evaluate the combined 
effect of these two variants on T1R susceptibility. We observed 
that the (G–T) haplotype, i.e., absence of T1R susceptibility alleles 
(A–C) for rs6478108 and rs7863183, was significantly protective 
for T1R in the overall sample (p =  0.0009; Table  4). However, 
the most striking observation was in the <30  years group at 
leprosy diagnosis category where all the alternative haplotypes 
FigUre 2 | age at leprosy diagnosis stratified association analysis of rs6478108 in TNFSF15 and type-1 reaction (T1r). The top panels indicate the 
strength of genetic effect as odds ratio (OR) for the four populations and the combined sample. Results are shown for three age strata and the entire sample 
regardless of age. Each colored circle represents the OR for each population sample with vertical lines delimiting their respective 95% confidence intervals (CIs). 
Dotted lines in the CI represent values that extend beyond the y-axis limits. The bottom panel presents the percentage of T1R-affected cases in each age stratum.
TaBle 3 | Multivariable analysis in the combined population samples.
all ages <30
single-nucleotide variant allele p Valueunivariable Odds ratio (Or) [95% 
confidence interval (ci)]
p Valuemultivariable p Valueunivariable Or (95% ci) p Valuemultivariable
rs6478108 G 1.50E−05 1.46 (1.23–1.73) 0.02 2.50E−08 1.95 (1.54–2.46) 0.0007
rs7863183 T 1.80E−05 1.35 (1.18–1.56) 0.004 1.10E−04 1.47 (1.21–1.79) 0.01
rs3181348 G 6.50E−06 1.40 (1.21–1.62) 0.28 5.80E−06 1.63 (1.32–2.01) 0.72
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(A–C, A–T, and G–C) were protective when compared to the 
haplotype containing both T1R risk alleles (G–T) for rs6478108 
and rs7863183 (Table 4).
DiscUssiOn
Here, we showed the age-dependent association of rs6478108 with 
T1R in ethnically distinct and geographically separated popula-
tions. By contrast, the association of rs3181348 and rs7863183 
with T1R was not restricted to early-onset leprosy cases. Albeit 
the model selected first by the multivariable analysis indicated 
rs6478108 and rs7863183 as independent signals of association 
with T1R, this model was not statistically different from the 
model encompassing rs6478108 and rs3181348. This suggests that 
the association of rs6478108 with T1R was independent of both 
rs7863183 and of our previous findings reporting the association 
of rs3181348 with T1R (8). While rs6478108 is one of the two 
independent signals of association with T1R, the second signal 
could not be unambiguously assigned to rs7863183 or rs3181348 
as both captured the same information. The estimated risk effect 
for both rs6478108 and rs7863183 in the overall population 
(OR =  1.46 and OR =  1.35, respectively) presented borderline 
significant p values for heterogeneity across the samples in the I2 
test (Table 2; Table S2 in Supplementary Material). This observa-
tion may be due to winner’s curse where the risk effects estimated 
in an initial scan are stronger than the risk effect observed in rep-
lication samples (19, 20). Irrespectively, the consistent association 
of TNFSF8/TNFSF15 variants with T1R in multiple populations 
reinforces the finding of rs7863183 and rs6478108 as global risk 
factor for T1R. The haplotype analysis indicated that subjects 
6Fava et al. Genetics of Leprosy Type-1 Reaction
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carrying T1R risk alleles in both rs6478108 and rs7863183 locus 
were significantly more susceptible to T1R compared to subjects 
carrying a T1R risk allele only in one of the two loci. The two 
SNVs independently associated with T1R have been reported as 
expression quantitative trait loci. Both rs6478108 and rs7863183 
are associated with TNFSF8 gene expression levels in peripheral 
blood (21) and in circulating monocytes (22) where the T1R 
risk alleles rs6478108-G and rs7863183-T correlated with higher 
gene expression. Interestingly, rs6478108 was also associated with 
TNFSF15 gene expression in a tissue dependent manner (23). 
While the rs6478108-G allele correlated with higher TNFSF15 
expression in the esophagus and the lungs, the rs6478108-A allele 
correlated with higher TNFSF15 expression in whole blood and 
in the liver (23).
The rs6478108 was originally reported as a leprosy per  se 
susceptibility factor by a genome-wide association study in a 
Chinese population sample (24). Thereafter, subsequent studies 
failed to replicate the rs6478108 association with leprosy per se 
in independent populations (25, 26). Our group observed asso-
ciation of rs6478108 only with T1R but not leprosy per se, and 
here, we showed that the strength of association was strongly 
age dependent. The TNFSF15/TNFSF8 region is a well-known 
locus associated with Crohn’s disease (CD) susceptibility (27). 
Multiple variants including rs6478108 and rs7863183 have 
been identified as risk factors for CD in distinct populations. 
The TNFSF15/TNFSF8 locus was strongly implicated in CD in 
populations from East Asian origin where the T1R risk alleles 
rs6478108-G and rs7863183-T were shown to be strong CD 
risk factors (p = 2.97E−45; OR = 1.90, CI 95% = 1.73–2.07 and 
p = 2.30E−25; OR = 1.56, CI 95% = 1.44–1.70, respectively) (27). 
Interestingly, in a candidate gene approach, we recently showed 
that SNVs in the LRRK2 gene presented the same risk alleles for 
T1R and CD (7, 28). Taken together, our results indicate a shared 
genetic component predisposing an individual to pathological 
inflammatory responses in leprosy and inflammatory bowel 
disease.
The mechanisms of genetic predisposition to disease are 
often closely connected with the age at onset of the disease. The 
interplay of age at onset and genetic control of disease is well 
known in neurodegenerative disorders. For instance, mutations 
in the PARK2 gene are classic examples of early-onset Parkinson’s 
disease, while mutations in the LRRK2 gene are the most frequent 
cause of late-onset autosomal-dominant Parkinson’s disease (29, 
30). In infectious diseases, the effect of age on the genetic control 
of disease is further complicated by the necessity of exposure and 
infection by the causative pathogen. Length and intensity of expo-
sure to the pathogen, as well as strain virulence, are factors that 
may affect early or late disease manifestation. With the advent of 
next-generation sequencing, studies have identified single-gene 
mutations as cause of extreme early-onset mycobacterial and/
or viral infection diseases (31–33). While these mutations are 
rare and family specific, the cumulative effect of rare variants on 
early-onset infectious disease remains unknown. It is possible 
that early-onset infectious disease is controlled by multiple rare 
and common variants in several genes that together have mod-
erate penetrance. The genetic control for early-onset infectious 
disease is distinct from late-onset/idiopathic infections (34). In 
late-onset cases of infection, a long history of host–environment 
interactions, the epigenome, somatic mutations, and cell senes-
cence are more likely to contribute to host genetic susceptibility 
(35).
In conclusion, we have shown that a group of SNVs that 
regulate TNFSF15 and TNFSF8 gene expression are associated 
with T1R in four independent populations. While the associa-
tion tagged by rs7863183 and rs3181348 was observed in all age 
categories, the rs6478108 association with T1R was dependent on 
the age at leprosy diagnosis. The age dependency of association 
suggests that the genetic control of gene expression varies across 
the human life span.
aUThOr cOnTriBUTiOns
VF, AA, and ES designed the study; VF performed the data 
analysis; VF, ES, CS-M, and MM interpreted the results; VF 
and ES wrote the manuscript; CS-M and MM reviewed the 
manuscript.
acKnOWleDgMenTs
The authors thank all leprosy patients and their family who par-
ticipated in this study. The authors are grateful to Dr. Marianna 
Orlova from McGill University, Canada; Dr. Nguyen Van Thuc 
and Dr. Vu Hong Thai from the Hospital for Dermato-Venerology, 
Vietnam; Dr. Mariane M. A. Stefani from the Tropical Pathology 
and Public Health Institute, Federal University of Goiás, Brazil; 
and Dr. Ana Carla P. Latini and Dr. Andrea F. Belone from the 
Lauro de Souza Lima Institute, Brazil, for recruiting the samples 
enrolled in this study.
FUnDing
This work was supported by a Foundation grant from the 
Canadian Institutes of Health Research (CIHR) to ES and a grant 
of the Agence Nationale de la Recherche (ANR) to AA.
sUPPleMenTarY MaTerial
The Supplementary Material for this article can be found 
online at http://journal.frontiersin.org/article/10.3389/fimmu. 
2017.00155/full#supplementary-material.




Odds ratio (Or) [95% 
confidence interval (ci)]
p Value Or (95% ci) p 
Value
G–T Baseline Baseline
G–C 0.76 (0.55–1.06) 0.10 0.70 (0.55–0.89) 0.004
A–T 0.75 (0.61–0.92) 0.005 0.80 (0.68–0.93) 0.005
A–C 0.73 (0.61–0.88) 0.0009 0.83 (0.74–0.94) 0.004
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